-
Founded in:
1992-07-09 -
Country:
China -
Address:
Room 801, No. 103, Guangcong 5th Road, Baiyun District, Guangzhou -
Tax NO.:
91440101708248300J -
Registered Funds:
150.1 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Astragali Radix |
|
0 | ||
| Atractylodes macrocephala (fried in soil) |
|
0 | ||
| SAPOSHNIKOVIAE RADIX |
|
0 | ||
| Anise oil |
|
8007-70-3 | 10 | |
| ASIAN GINSENG |
|
0 | ||
| Ophiopogonis Radix |
|
0 | ||
| Radix Aconiti Lateralis Preparata Rhizoma Cyperi extract |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Artemisiae Scopariae Herba |
|
0 | ||
| Taraxasterol |
|
0 | ||
| Anise oil |
|
8007-70-3 | 10 | |
| Poria |
|
0 | ||
| Hawthorn |
|
0 | ||
| Astragali Radix |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Angelicae Sinensis Radix |
|
0 | ||
| Astragali Radix |
|
0 | ||
| Jujubae Fructus |
|
0 | ||
| Sucrose |
|
57-50-1 | 71 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-carnitine |
Promote lipid metabolism, increase energy production, improve energy supply to tissues and organs, participate in drug detoxification, oxidation of medium-chain fatty acids, oxidation of fatty acid peroxidase, buffer the ratio of bound coenzyme A to free coenzyme A, generate energy from ketones, pyruvate, and amino acids (including branched-chain amino acids), remove excessive coenzyme A toxicity, and regulate blood ammonia concentration.
More
Promote lipid metabolism, increase energy production, improve energy supply to tissues and organs, participate in drug detoxification, oxidation of medium-chain fatty acids, oxidation of fatty acid peroxidase, buffer the ratio of bound coenzyme A to free coenzyme A, generate energy from ketones, pyruvate, and amino acids (including branched-chain amino acids), remove excessive coenzyme A toxicity, and regulate blood ammonia concentration. |
541-15-1 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.
More
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats. |
189224-26-8 | 10 |